Literature DB >> 24880143

CD73 expression in RPE cells is associated with the suppression of conventional CD4 cell proliferation.

Song Chen1, Shumin Zhou2, Kai Zang3, Fanqiang Kong1, Dongchun Liang4, Hua Yan5.   

Abstract

CD73 is intensively involved in the regulation of immune responses through the conversion of pro-inflammatory ATP to immunosuppressive adenosine. Herein, we clarified whether cells in the retina express CD73 and participate in the regulation of inflammatory eye diseases such as experimental autoimmune uveitis (EAU). First, immunofluorescence staining was performed to compare the distribution of CD73(+) cells in the retinas of EAU-induced and normal B10RIII mice. The results revealed that a layer of cells in the normal retina that was consistent with the location of retinal pigment epithelial (RPE) cells strongly expressing CD73, and the expression was markedly reduced in the presence of EAU. Thereafter, EAU was also induced in C57BL/6 mice by active immunization or adoptive transfer. CD73 expression in isolated RPE cells was assessed by real-time RT-PCR and western blotting, and the catalytic abilities of the cells to convert AMP to adenosine were determined using HPLC analyses. Compared to the normal control, significantly decreased CD73 expression and AMP catalytic ability were found in the RPE cells isolated from inflamed eyes. CD73 expression and activity were also studied in cultured RPE cells treated with different stimuli, such as Toll-like receptor ligands and cytokines. Highly varied functional CD73 expression was observed in RPE cells through cytokines or Toll-like receptor agonist treatments. Finally, whether RPE cells could regulate the immune response, particularly the proliferation of CD4 cells, through surface-expressed CD73 was determined using a two-chamber assay. The robust inhibition of conventional T-cell proliferation was uniquely observed when CD73(+) RPE cells in the upper chamber were in the presence of AMP. To further confirm the function of CD73 in RPE cells, Cd73(-/-) RPE cells were isolated, and CD73-rescued control cells were constructed. CD73(+)Cd73(-/-) RPE, not Cd73(-/-) RPE, significantly suppressed interacted CD4 cells proliferation and cytokine production. Taken together, these data suggest that naive RPE cells suppressed the immune response through their high expression of CD73. The expression of CD73 in RPE cells could be regulated through many factors, and down-regulated CD73 expression attenuated the suppressive effect of RPE on the proliferation of conventional CD4 cells.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD4 cells; CD73; RPE; inhibition

Mesh:

Substances:

Year:  2014        PMID: 24880143     DOI: 10.1016/j.exer.2014.05.008

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  4 in total

1.  Multiple steps determine CD73 shedding from RPE: lipid raft localization, ARA1 interaction, and MMP-9 up-regulation.

Authors:  Wei Zhang; Shumin Zhou; Guoping Liu; Fanqiang Kong; Song Chen; Hua Yan
Journal:  Purinergic Signal       Date:  2018-11-03       Impact factor: 3.765

2.  Phenotypic and Functional Signatures of Herpes Simplex Virus-Specific Effector Memory CD73+CD45RAhighCCR7lowCD8+ TEMRA and CD73+CD45RAlowCCR7lowCD8+ TEM Cells Are Associated with Asymptomatic Ocular Herpes.

Authors:  Ruchi Srivastava; Pierre-Grégoire Coulon; Soumyabrata Roy; Sravya Chilukuri; Sumit Garg; Lbachir BenMohamed
Journal:  J Immunol       Date:  2018-09-10       Impact factor: 5.422

Review 3.  Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy.

Authors:  Simone de Leve; Florian Wirsdörfer; Verena Jendrossek
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

4.  Pro-inflammatory Effect of Downregulated CD73 Expression in EAE Astrocytes.

Authors:  Shumin Zhou; Guoping Liu; Jie Guo; Fanqiang Kong; Song Chen; Zhiyun Wang
Journal:  Front Cell Neurosci       Date:  2019-05-29       Impact factor: 5.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.